已收盘 05-15 16:00:00 美东时间
-0.300
-1.30%
今日重点评级关注:Citizens:维持BioCryst制药"跑赢大市"评级,目标价从25美元升至28美元;富国银行:维持曼恩凯德生物医疗"超配"评级,目标价从8美元升至10美元
05-08 12:05
今日重点评级关注:Piper Sandler:维持Aclaris Therapeutics"超配"评级,目标价从7美元升至11美元;Evercore ISI集团:维持BioMarin Pharmaceutical"跑赢大市"评级,目标价从110美元升至120美元
05-06 11:29
BTIG analyst Ryan Zimmerman maintains Tactile Systems Tech (NASDAQ:TCMD) with a Buy and raises the price target from $38 to $40.
05-05 18:09
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Tactile Systems业绩会实录,以下是2026年第一季度财务业绩回顾摘要: ## 1. 财务业绩 **营收表现:** - 总营收7,530万美元,同比增长23% - 淋巴水肿业务营收6,220万美元,同比增长23% - 气道清理业务营收1,300万美元,同比增长22% **盈利能力:** - 毛利率76.5%,较去年同期74%提升250个基点 - GAAP营业亏损150万美元,较去年同期450万美元亏损大幅改善66% - 净亏损180万美元(每股亏损0.08美元),较去年同期300万美元亏损(每股亏损0.13美元)改善41% - 调整后
05-05 12:30
Tactile Systems Tech (NASDAQ:TCMD) reported first-quarter financial results on ...
05-05 06:09
Tactile Systems Tech (NASDAQ:TCMD) raises FY2026 sales outlook from $357.000 million-$365.000 million to $360.000 million-$368.000 million vs $360.528 million estimate.
05-05 04:18
Companies Reporting Before The Bell • Pulse Biosciences (NASDAQ:PLSE) is likely...
05-04 19:11
Tactile Medical appoints Andrea Pearson to its Board of Directors, effective March 9, 2026. Pearson, a seasoned healthcare executive with over 25 years of experience, will also serve on the Compliance & Reimbursement and Nominating & Corporate Governance Committees. Her expertise in scaling healthcare organizations, product development, and marketing is expected to support Tactile Medical's growth and market leadership in addressing chronic condi...
03-09 12:00
Rackspace飙升227%,Palantir达成重磅合作;IBRX大涨41%,治疗膀胱癌卡介苗获欧盟上市许可;贵金属生产商HYMC大涨24%,金银价格再起升势,黄金涨破5000美元>>
02-19 17:52